HuR is widely expressed by tumors, and suramin targets HuR [106,107] and inhibits HuR function to effectively suppress progressive oral cancer that cannot be treated using other anticancer agents [108]. This evidence concerns the gene ELAVL1 and lip and oral cavity carcinoma.